A technology has been developed that can screen for lung cancer at an early stage using exhaled breath. This technology demonstrated 95% accuracy in clinical settings. It is expected to contribute to ...
SAN DIEGO, Oct. 1, 2025 /PRNewswire/ -- A groundbreaking study published in Translational Lung Cancer Research reveals the potential of LungCanSeek, a novel blood test that uses four protein markers ...
(a) Deep learning-based circulating exosome analysis for lung cancer detection (copyright American Chemical Society, 2024); (b) The operational mechanism of the Förster resonance energy transfer (FRET ...
All study participants simultaneously underwent NGS using three sample types: (1) BWF, (2) plasma, and (3) tumor tissue collected during bronchoscopy. The full patient set (FPS) included all enrolled ...
NeXT Personal identifies circulating tumor DNA in 81% of early-stage lung adenocarcinoma cases, offering potential for better disease stratification and outcome prediction. Study: Ultrasensitive ctDNA ...
Higher mortality rates due to lung cancer may be avoided if there is increased early detection of the disease, medical experts said on Thursday, as they pushed for the use of artificial intelligence ...
Electronic nose breath analysis achieved 80-92% accuracy for detecting lung cancer in patients with suspicious findings. Detection accuracy remained consistent across tumor characteristics, disease ...
Lung cancer symptoms are often non-specific, leading to late detection and misattribution to less severe conditions. The GO2 for Lung Cancer provides resources, policy advocacy, and access to clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results